ID1 and chronic inflammatory demyelinating polyradiculoneuropathy: We hypothesized that in CIDP, IVIg treatment may result in the formation of new Id-anti-Id complexes that could be assessed by quantification of Ig dimers in post-treatment serum of CIDP patients.